Baltic Atherosclerosis Conference 2021

03.12.2021 - 04.12.2021  Tallinn, Estonia

Lessons learned from Latvian Early Atherosclerosis registry

Laima Caunīte (Latvia)
Cardiologist, Pauls Stradins Clinical University Hospital
Biography: Laima Caunīte is a Resident Cardiologist in Pauls Stradins Clinical University Hospital and a Cardiology tutor in Riga Stradins University. She has been actively contributing to patient inclusion in Early Atherosclerosis Registry since its initiation in 2019 and is a co-author of peer reviewed publications about Early Atherosclerosis and Arrhythmogenic Right Ventricular Cardiomyopathy. Her main interests are in the field of coronary artery disease in the young and diabetes with a plan for specialisation in Interventional Cardiology and Intensive Care.

Small Hall

Media:

  • view the video of this presentation
  • Synopsis: Coronary artery disease (CAD) remains one of the most common death causes. It can potentially worsen quality of life and decrease the number of work years not only in elderly, but also in young people. Latvian Early Atherosclerosis Registry is an ongoing project developed to examine the most common risk factors in this population, to increase compliance and monitor patients in the long term. Registry includes males younger than 55 and females younger than 65 years. After written consent is obtained, patients are interviewed for risk factors. Coronary angiography, echocardiography and blood test data are collected. Results are analysed by SPSS 27. 341 patients were included (218 males, mean age 48.94 ± 4.91 and 123 females, mean age 57.94 ± 5.09), 70 were hospitalised due to acute coronary syndrome (ACS), 271 for elective percutaneous coronary intervention. 145 patients have had a two year follow-up visit (FUV). Most common risk factor was arterial hypertension - 286 (83.87%). Upon inclusion low density cholesterol (LDL) > 3.00 mmol/l was observed in 33 patients (30.8%), on FUV in 17 (15.9%). LDL <1.4 mmol/l upon inclusion was in 12 (11.2%) patients, on FUV - in 37 patients (34.6%). Overall LDL decreased from 2.64 ± 1.31 mmol/l upon inclusion to 2.16 ± 1.42 mmol/l on FUV (p<0.01). At the time of inclusion 277 (81.2%) patients used statins, 264 (77.5%) used antiplatelets. At the two year FUV statins were used by 130 (89.7%), antiplatelets by 118 (81.4%). Coronary artery disease is a potentially debilitating burden in young patients. We have observed improved risk factor control in Early Atherosclerosis Registry patients on follow-up, though it remains suboptimal.

    This agenda item is presented in the following session: S2 - Early atherosclerosis, hypertension and personalised prevention

    Plenary session

    03.12.2021 11:45 - 13:15